Later, Huzarski et al. [18] performed a study to estimate 10-year OS rates for patients with early-onset breast cancer with or without BRCA1 mutation and identify prognostic factors among those with BRCA1-positive breast cancer. This evidence concerns the gene BRCA1 and breast cancer.